Filing Analysis
Pluri Inc. entered into a securities purchase agreement for a registered direct offering and a concurrent private placement involving common shares and warrants. The offering aims to raise approximately $2.98 million to fund corporate development and working capital.
🚩 Red Flags
- Significant dilution: The issuance of over 1 million shares plus warrants for a relatively small amount of capital ($2.98M) suggests high dilution for existing shareholders.
- Warrant overhang: The issuance of 2.2 million common warrants at $1.65 creates significant future dilution potential.
- Use of proceeds: Proceeds are earmarked for 'working capital,' which often indicates a need to cover immediate operational burn rather than specific growth projects.
📋 Key Facts
- Registered Direct Offering: 1,200,000 common shares at $1.50 per share.
- Pre-Funded Warrants: 1,028,940 warrants at $1.49999 per share (exercise price of $0.00001).
- Concurrent Private Placement: 2,228,940 common warrants with an exercise price of $1.65 per share, exercisable in 6 months.
- Expected net proceeds: Approximately $2,984,808 after fees and expenses.
- Placement Agent: A.G.P./Alliance Global Partners (6.50% cash fee).
- Lock-up: Directors and officers are subject to a 45-day lock-up period following closing.
Pluri Inc. is providing an update on ongoing negotiations with the European Investment Bank (EIB) regarding a €50 million loan that was due for repayment on June 1, 2026. While discussions are described as 'advancing constructively,' the company faces significant uncertainty regarding whether a resolution will be reached or if the EIB will exercise legal remedies.
🚩 Red Flags
- The loan maturity date (June 1, 2026) has already passed without a finalized extension/resolution.
- Potential for EIB to exercise legal remedies or enforcement actions if negotiations fail.
- Significant liquidity risk implied by the need for a resolution on a major debt obligation.
- Uncertainty regarding the outcome of internal EIB approval processes.
📋 Key Facts
- The EIB Loan involves up to €50 million in funding (first tranche of €20 million disbursed in June 2021).
- The loan bears interest at 4% per annum and was scheduled for repayment on June 1, 2026.
- Negotiations regarding a potential extension or resolution are currently subject to the EIB's internal approval process and legal review.
- As of July 3, 2026, the company had not yet reached a definitive resolution with the lender.
Pluri Inc. received a notice from Nasdaq stating it is non-compliant with the minimum market value of listed securities (MVLS) requirement under Rule 5550(b)(2). The company has been granted an initial compliance period until January 4, 2027, to regain compliance.
🚩 Red Flags
- Delisting notice from Nasdaq (Rule 5550(b)(2))
- Failure to meet alternative listing standards regarding equity and net income
- Requirement to maintain $35M in market value of listed securities not being met
📋 Key Facts
- Received notice from Nasdaq on July 7, 2026.
- Non-compliance with Nasdaq Listing Rule 5550(b)(2) regarding the $35 million MVLS requirement.
- Company also failed alternative listing standards (stockholders' equity of $2.5M or net income of $500k).
- Compliance period granted until January 4, 2027.
- Trading continues on Nasdaq under symbol 'PLUR' during the compliance period.
Pluri Inc. entered into a $1.25 million Advance Subscription Agreement with Chutzpah Holdings LP, an entity beneficially owned by the Company's Board Chairman, Mr. Alexandre Weinstein. The filing also notes the departure of director Eitan Ajchenbaum and the appointment of Doron Shorrer to fill his vacancy.
🚩 Red Flags
- Related-party transaction: The $1.25M advance comes from a company controlled by the Board Chairman.
- Potential liquidity pressure: Use of an 'advance' for working capital suggests immediate cash needs.
- Uncertainty regarding future financing: The conversion of the advance depends on a future offering to be negotiated and approved by August 14, 2026.
📋 Key Facts
- On June 14, 2026, Pluri entered an Advance Subscription Agreement with Chutzpah Holdings LP for $1,250,000.
- The Purchaser (Chutzpah Holdings LP) is beneficially owned by Mr. Alexandre Weinstein, the Chairman of the Board.
- The $1.25 million was received on June 16, 2026, intended for working capital and general corporate purposes.
- The funds are to be credited against a future financing (the 'Offering') expected to be consummated by August 14, 2026.
- Director Eitan Ajchenbaum was not re-elected at the 2026 Annual Meeting on June 15, 2026.
- Mr. Doron Shorrer has been elected to fill the vacancy left by Mr. Ajchenbaum; he is designated as an audit committee financial expert.
Pluri Inc. is reporting on the status of a €20 million loan from the European Investment Bank (EIB) that reached its maturity date on June 1, 2026. While the EIB has agreed to refrain from enforcement action until July 3, 2026, to allow for 'constructive discussions' regarding a resolution or extension, the company cannot guarantee a favorable outcome.
🚩 Red Flags
- The loan has already reached its maturity date (June 1, 2026) without being repaid.
- The company is effectively in a state of technical default or extreme urgency, relying on the lender's discretion to avoid enforcement.
- The EIB previously issued a notice on April 21, 2026, reserving all rights, indicating a history of tension regarding this debt.
📋 Key Facts
- The EIB Loan consists of a €20 million disbursed tranche from a larger €50 million facility.
- The loan carries an interest rate of 4% per annum.
- The loan maturity date was June 1, 2026.
- The EIB has provided a temporary window until July 3, 2026, during which no enforcement action is currently contemplated.
- The EIB reserves all rights to take action if discussions do not result in an acceptable outcome.
Pluri Inc. entered into a $2.5 million private placement agreement with Chutzpah Holdings LP, an entity controlled by company director Alexandre Weinstein. The offering consists of 625,000 common shares and an equal number of warrants at a combined price of $4.00 per unit.
🚩 Red Flags
- Related-party transaction: The primary investor is an existing director and shareholder.
- Significant dilution potential: 100% warrant coverage (one warrant for every share purchased).
- Short-term warrant duration (18 months) may create selling pressure in the near term.
📋 Key Facts
- Agreement date: March 25, 2026.
- Investor: Chutzpah Holdings LP, beneficially owned by director Alexandre Weinstein.
- Securities: 625,000 common shares and 625,000 warrants.
- Unit price: $4.00 per share/warrant combination.
- Warrant exercise price: $4.25 per share with an 18-month expiration.
- Gross proceeds: Approximately $2.5 million.
- Expected closing: End of April 2026.
Pluri Inc. has regained compliance with Nasdaq's minimum market value requirement of $35 million for continued listing. The company had previously been notified of non-compliance on January 20, 2026, after failing to meet market value, stockholders' equity, and net income standards.
🚩 Red Flags
- The company recently failed all three alternative Nasdaq listing standards (Market Value, Equity, and Net Income), indicating a precarious financial position.
- Market capitalization is hovering near the minimum $35 million threshold, suggesting high sensitivity to stock price fluctuations.
📋 Key Facts
- On February 27, 2026, Nasdaq confirmed the company regained compliance with Listing Rule 5550(b)(2).
- Compliance was achieved by maintaining a market value of listed securities of $35 million or greater for 10 consecutive business days from February 13 to February 26, 2026.
- The company was previously deficient in alternative standards including stockholders' equity of at least $2.5 million and net income of $500,000.
- The matter is now closed and the company remains listed on The Nasdaq Capital Market.
Pluri Inc. received a notice from Nasdaq stating it is non-compliant with the minimum market value of listed securities (MVLS) requirement. The company has an 180-day compliance period ending July 20, 2026, to regain compliance.
🚩 Red Flags
- Failure to meet minimum market value requirement (MVLS).
- Failure to meet alternative equity and net income thresholds.
- Risk of delisting if compliance is not achieved by July 20, 2026.
- Potential for a delisting appeal process which introduces significant uncertainty.
📋 Key Facts
- Received written notice from Nasdaq on January 20, 2026.
- Non-compliance with Nasdaq Listing Rule 5550(b)(2) regarding the $35 million MVLS requirement.
- Company failed to meet alternative standards: stockholders' equity of $2.5 million or net income of $500,000 from continuing operations in the most recent fiscal year.
- Compliance period granted until July 20, 2026.
- Trading continues on Nasdaq under symbol 'PLUR' during the compliance period.
Pluri Inc. entered into a $2.5 million securities purchase agreement with Chutzpah Holdings LP, an entity beneficially owned by Director Alexandre Weinstein. The offering includes 625,000 common shares and warrants to purchase an additional 625,000 shares at a combined price of $4.00 per unit.
🚩 Red Flags
- Related-party transaction: The primary purchaser is an entity owned by a sitting Director.
- Potential dilution: Issuance of 625,000 shares plus warrants for 625,000 additional shares.
- Liquidity/Capital Need: Use of proceeds for 'working capital' often indicates immediate cash flow needs.
📋 Key Facts
- Date of Agreement: December 8, 2025
- Purchaser: Chutzpah Holdings LP (beneficially owned by Director Alexandre Weinstein)
- Securities Offered: 625,000 common shares and 625,000 warrants
- Combined Price per Unit: $4.00
- Warrant Terms: Exercise price of $4.25; expires June 30, 2026
- Expected Gross Proceeds: Approximately $2.5 million
- Use of Proceeds: Working capital and general corporate purposes
- Board Changes: Mr. Weinstein appointed Chairman; Mr. Zami Aberman appointed Vice Chairman (effective Dec 4, 2025); Mr. Aberman's consultancy to end Jan 4, 2026
Pluri Inc. announced that its Board of Directors approved equity awards for CEO Yaky Yanay in recognition of performance during fiscal year 2025. The compensation package includes both immediate fully vested RSUs/options and potential future grants contingent on year-end objectives.
🚩 Red Flags
- None identified in this specific filing.
📋 Key Facts
- Approved grant to CEO Yaky Yanay: 39,050 restricted stock units (RSUs) - fully vested.
- Approved grant to CEO Yaky Yanay: 39,050 stock options with a $5.00 exercise price - fully vested and exercisable for three years.
- Contingent future grant (if objectives met by Dec 31, 2025): 9,266 RSUs and 9,266 stock options at a $5.00 exercise price.
Pluri Inc. has successfully regained compliance with Nasdaq's Audit Committee independence requirements following the election of a new independent director. This resolves a previous non-compliance issue that had placed the company at risk of delisting.
🚩 Red Flags
- Previous non-compliance with Nasdaq listing rules regarding board independence.
📋 Key Facts
- The Company was previously in violation of Nasdaq Listing Rule 5605(c)(2)(A) due to the Audit Committee failing independence requirements.
- Non-compliance originated from the non-election of a director during the annual shareholders meeting on June 30, 2025.
- On September 11, 2025, Mr. Eitan Ajchenbaum was elected as an independent director and Chairman of the Audit Committee.
- Nasdaq has officially confirmed that the Company has regained compliance and the matter is closed.
Pluri Inc. announced the election of Eitan Ajchenbaum to its Board of Directors, effective September 10, 2025. Mr. Ajchenbaum will fill a vacancy left by Doron Birger and will serve as Chairman of the Audit Committee and sole member of the Investment Committee.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Eitan Ajchenbaum elected to the Board on September 10, 2025.
- Fills vacancy created by the departure of Doron Birger following the June 30, 2025 annual meeting.
- Mr. Ajchenbaum appointed as Chairman of the Audit Committee and designated as an audit committee financial expert.
- Mr. Ajchenbaum will also serve as the sole member of the Investment Committee.
- Mr. Ajchenbaum has extensive finance experience, including roles at WeSure Global Tech Ltd., Berkshire Hathaway Guard, and Bezeq International Ltd.
Pluri Inc. reported that following the non-re-election of director Doron Birger at the 2025 Annual Meeting, the company is no longer in compliance with Nasdaq's Audit Committee independence requirements. Nasdaq has granted a cure period to regain compliance by June 30, 2026.
🚩 Red Flags
- Delisting risk: Non-compliance with Nasdaq Audit Committee independence rules.
- Governance instability: Loss of an independent director and Audit Committee Chair via shareholder vote.
- Potential for future delisting if a replacement is not appointed within the cure period.
📋 Key Facts
- Doron Birger was not re-elected to the Board on June 30, 2025, and ceased serving as an independent director and Audit Committee Chairman.
- The company is currently non-compliant with Nasdaq Listing Rule 5605(c)(2)(A) regarding Audit Committee composition.
- Nasdaq provided a cure period expiring no later than June 30, 2026.
- The company intends to appoint an additional independent director to restore compliance.
- Shareholders approved the ratification of Kesselman & Kesselman as independent auditors for FY ending June 30, 2025.
Pluri Inc. has announced the rescheduling of its 2025 Annual Meeting of Shareholders from May 23, 2025, to June 30, 2025. The record date for determining voting shareholders was reset to the close of business on May 23, 2025.
📋 Key Facts
- The 2025 Annual Meeting is rescheduled from May 23, 2025, to June 30, 2025, at 4:00 p.m. Israel time.
- The meeting will be held at the Company's office in Haifa, Israel.
- The record date for shareholder voting eligibility was reset to May 23, 2025.
Pluri Inc. has successfully regained compliance with Nasdaq listing requirements after meeting the market value threshold. The company is no longer under deficiency notice regarding its stockholders' equity requirement.
🚩 Red Flags
- Historical non-compliance with minimum stockholders' equity requirements (though now resolved).
📋 Key Facts
- The Company was previously non-compliant with Nasdaq Listing Rule 5550(b)(1) regarding a $2,500,000 minimum stockholders' equity requirement.
- Nasdaq granted an extension to regain compliance until May 24, 2025.
- On May 7, 2025, Nasdaq determined the Company regained compliance via Rule 5550(b)(2).
- Compliance was achieved because the market value of listed securities was $35 million or greater for 10 consecutive business days (April 22, 2025 – May 6, 2025).
- The deficiency matter is officially closed and the company remains in good standing on Nasdaq.
Pluri Inc. announced the scheduling of its 2025 Annual Meeting of Shareholders to be held on May 23, 2025. The filing also notes a change in the meeting date relative to the previous year's anniversary.
📋 Key Facts
- The 2025 Annual Meeting of Shareholders is scheduled for Friday, May 23, 2025, at 5:00 p.m. Israel time.
- Meeting location: MATAM Advanced Technology Park Building No. 5, Haifa, Israel.
- Record date for voting eligibility was the close of business on March 24, 2025.
- The meeting date represents a change of more than 30 days from the anniversary of the 2024 Annual Meeting.
Pluri Inc. has completed the acquisition of approximately 71% of Kokomodo Ltd., making it a majority-owned subsidiary. The transaction was settled via an equity issuance rather than cash.
🚩 Red Flags
- The acquisition was settled entirely through the issuance of common shares, which results in dilution for existing shareholders.
📋 Key Facts
- Acquisition date: April 28, 2025
- Target: Approximately 71% of the equity in Kokomodo Ltd.
- Consideration: $4.5 million payable in 976,139 Common Shares of Pluri Inc.
- Structure: Kokomodo will continue to operate as an independent company and a majority-owned subsidiary.
Pluri Inc. entered into an amendment to a Securities Purchase Agreement with a company wholly-owned by Director Alejandro Weinstein. The amendment involves exchanging 976,139 common shares for pre-funded warrants with a nominal exercise price of $0.0001 per share.
🚩 Red Flags
- Related-party transaction involving a Director (Alejandro Weinstein).
- Significant dilution potential via the exchange of common shares for pre-funded warrants.
- Nominal exercise price ($0.0001) effectively makes the warrants nearly equivalent to free equity upon exercise.
- Securities issued are unregistered and exempt under Section 3(a)(9) of the Securities Act.
📋 Key Facts
- Date of Amendment: April 25, 2025
- Counterparty: A company wholly-beneficially owned by Mr. Alejandro Weinstein (a Director of the Company).
- Transaction Detail: Exchange of 976,139 common shares for additional pre-funded warrants.
- Warrant Terms: Exercise price of $0.0001 per share; includes customary anti-dilution provisions and a 19.99% beneficial ownership limitation pending shareholder approval.
- Previous Issuance: Investor previously held 1,383,948 common shares, pre-funded warrants for 26,030 shares, and warrants for 84,599 shares.
Pluri Inc.'s subsidiary, Pluri Biotech Ltd., received a formal notice from the NIAID terminating a three-year contract for the development of PLX-R18 cell therapy. The termination was effective as of April 15, 2025, and was executed for the Government's convenience.
🚩 Red Flags
- Loss of significant non-dilutive funding ($4.2M) for a core development program (PLX-R18).
- Potential impact on R&D timelines and clinical progress for cell therapy programs.
- Uncertainty regarding future federal funding due to 'broader federal budgetary and administrative adjustments'.
📋 Key Facts
- Contract value: $4.2 million over three years.
- Termination date: Effective April 15, 2025.
- Reason for termination: 'Government's convenience'.
- Project scope: Development of PLX-R18 cell therapy for Hematopoietic Acute Radiation Syndrome (H-ARS).
- Collaborators involved in the program: U.S. Department of Defense AFRRI and USUHS.
- Original announcement date: July 11, 2023.
Pluri Inc. announced the scheduling of its 2025 Annual Meeting of Shareholders, which is set to take place on May 14, 2025.
📋 Key Facts
- The 2025 Annual Meeting of Shareholders will be held on Wednesday, May 14, 2025, at 5:00 p.m. Israel time.
- The meeting location is MATAM Advanced Technology Park Building No. 5, Haifa, Israel.
- The record date for determining shareholders entitled to vote is the close of business on March 24, 2025.
- The meeting date represents a change of more than 30 days from the anniversary of the 2024 Annual Meeting.
Pluri Inc. entered into a Share Purchase Agreement to acquire approximately 71.1% of Kokomodo via its subsidiary, Pluri Biotech Ltd. The transaction involves the issuance of 976,139 common shares (representing ~12.14% of equity) to Chutzpah Holdings Limited, a company wholly owned by Director Alejandro Weinstein.
🚩 Red Flags
- Related-party transaction: The Seller (Chutzpah Holdings Limited) is wholly owned by a Company Director (Mr. Alejandro Weinstein).
- Significant Dilution: Issuance of ~12.14% of the company's equity to a single insider-controlled entity.
- High Breakup Fee: A $1.5 million breakup fee represents a significant contingent liability if the deal fails.
📋 Key Facts
- Acquisition of Kokomodo: Purchaser will acquire 400,000 ordinary shares and 175,000 preferred seed-1 shares (approx. 71.1% equity).
- Consideration: Total purchase price of $4.5 million to be paid in 976,139 common shares of Pluri Inc.
- Debt Assumption: Purchaser will assume a convertible loan with a principal aggregate amount of $0.5 million from the Seller.
- Dilution: The issuance of Consideration Shares represents approximately 12.14% of the Company's fully diluted share capital as of Jan 23, 2025.
- Leak-Out Provision: Seller is subject to a leak-out agreement for a period of up to 36 months or until they hold less than 10% of the company.
- Breakup Fee: A $1.5 million breakup fee applies if the transaction is not consummated by May 23, 2025 (extendable to July 23, 2025).
- Closing Condition: Transaction is subject to customary closing conditions and requires shareholder approval.
Pluri Inc. entered into a Securities Purchase Agreement with existing shareholder Merchant Adventure Fund, L.P. for a private placement of common shares and warrants. The offering is expected to raise approximately $3.5 million in gross proceeds to be used for working capital.
🚩 Red Flags
- Related-party transaction (Investor is an existing shareholder)
- Dilutive offering (issuance of new common shares and warrants)
📋 Key Facts
- Date of agreement: February 3, 2025
- Investor: Merchant Adventure Fund, L.P. (existing shareholder)
- Securities issued: 759,219 common shares and warrants to purchase up to 45,553 common shares
- Common share price: $4.61 per share
- Warrant exercise price: $5.568 per share
- Warrant term: 3 years from closing
- Expected gross proceeds: ~$3.5 million
- Intended use of proceeds: Working capital and general corporate purposes
- Expected closing date: On or about February 20, 2025
Pluri Inc. entered into a $6.5 million private placement agreement with an investor, Alejandro Weinstein, which includes the issuance of common shares and warrants. The deal also involves a contingent term sheet for the acquisition of 71% of Kokomodo Ltd., alongside the appointment of Mr. Weinstein to the Board of Directors.
🚩 Red Flags
- Related-party transaction: The investor (Alejandro Weinstein) is being appointed to the Board as part of the financing deal.
- Potential dilution: Issuance of significant warrants and pre-funded warrants alongside common shares.
- Contingent liabilities: If the Kokomodo transaction fails, Pluri may be obligated to purchase $1M in Kokomodo shares and invest an additional $500k via SAFE.
📋 Key Facts
- Private placement offering of 1,383,948 common shares at $4.61 per share.
- Issuance of pre-funded warrants (26,030 shares) and common warrants (84,599 shares).
- Gross proceeds from the offering are expected to be approximately $6.5 million for working capital.
- Binding term sheet to purchase ~71% of Kokomodo Ltd. for $4.5 million in Common Shares.
- Mr. Alejandro Weinstein to be appointed to the Board of Directors upon closing.
- The offering is subject to Nasdaq shareholder approval regarding beneficial ownership limits.
Pluri Inc. has received an extension from Nasdaq to regain compliance with the Stockholders' Equity Requirement by May 24, 2025. The company is currently non-compliant with Nasdaq Listing Rule 5550(b)(1) regarding minimum stockholders' equity.
🚩 Red Flags
- Non-compliance with minimum stockholders' equity requirements (Rule 5550(b)(1))
- Risk of delisting if compliance is not achieved by May 24, 2025
- Potential for significant dilution or capital raises needed to meet equity thresholds
📋 Key Facts
- The company received a deficiency letter from Nasdaq on November 25, 2024.
- Non-compliance pertains to Nasdaq Listing Rule 5550(b)(1), requiring at least $2.5 million in stockholders' equity.
- A compliance plan was submitted to Nasdaq on January 6, 2025.
- Nasdaq has granted an extension to regain compliance until May 24, 2025.
- Failure to meet the deadline may result in delisting from the Nasdaq Capital Market.
Pluri Inc. received a deficiency letter from Nasdaq notifying the company that it is not in compliance with minimum stockholders' equity requirements for continued listing on the Nasdaq Capital Market.
🚩 Red Flags
- Delisting notice/Non-compliance with Nasdaq listing rules
- Failure to meet minimum stockholders' equity requirement ($2.5M)
- Failure to meet market value of listed securities threshold ($35M)
📋 Key Facts
- Received notice on November 25, 2024, regarding non-compliance with Nasdaq Listing Rule 5550(b)(1).
- The company failed to meet the $2.5 million minimum stockholders' equity requirement.
- The company also failed alternative standards: market value of listed securities of at least $35 million and net income requirements.
- Pluri has 45 calendar days from the date of the Nasdaq letter to submit a plan to regain compliance.
- If a plan is accepted, an extension of up to 180 calendar days may be granted to evidence compliance.
Pluri Inc. has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement. Following a deficiency notice issued in May 2024, the company submitted a compliance plan that was accepted, and Nasdaq has officially closed the matter.
🚩 Red Flags
- Historical non-compliance with minimum stockholders' equity requirements (Rule 5550(b)(1)) indicates past liquidity or capital structure distress.
📋 Key Facts
- The Company was previously non-compliant with Nasdaq Listing Rule 5550(b)(1) regarding the $2.5 million minimum stockholders' equity requirement.
- A deficiency letter was originally received on May 28, 2024.
- The Company submitted a compliance plan to Nasdaq on July 11, 2024.
- Nasdaq granted an extension to regain compliance until November 24, 2024.
- On September 26, 2024, Nasdaq determined the Company has regained compliance and closed the matter.
Pluri Inc. has received an extension from Nasdaq to regain compliance with the minimum stockholders' equity requirement of $2,500,000. The company must demonstrate compliance by November 24, 2024, or face potential delisting.
🚩 Red Flags
- Failure to meet minimum stockholders' equity requirement (Rule 5550(b)(1)).
- Risk of delisting from Nasdaq if compliance is not achieved by Nov 24, 2024.
- Potential for a reverse stock split in the future to artificially boost equity/share price to meet listing requirements.
📋 Key Facts
- The company is non-compliant with Nasdaq Listing Rule 5550(b)(1) regarding the $2.5 million stockholders' equity requirement.
- Nasdaq has granted an extension to regain compliance until November 24, 2024.
- Compliance plan was submitted on July 11, 2024.
- The company is currently trading under the symbol 'PLUR' on the Nasdaq Capital Market.
Pluri Inc. entered into a €1 million proof of concept (POC) agreement with an undisclosed leading international agriculture corporation to develop solutions for vegetable product supply using the company's 3D cell expansion technology.
🚩 Red Flags
- Counterparty is not named, making it difficult to assess the strength of the partnership.
- Termination rights allow the counterparty to exit easily after each phase.
📋 Key Facts
- Agreement value is €1 million.
- The counterparty is described as a 'leading international agriculture corporation'.
- Payment structure consists of three installments: upon effective date, after phase one completion/notification, and upon completion of phase two.
- The POC Party retains the right to terminate with 14 days' written notice following either phase.
Pluri Inc. announced the resignation of its CFO, Treasurer, and Secretary, Chen Franco-Yehuda, effective September 30, 2024. The company has named Liat Zalts, currently Director of Finance, as her successor starting on the same date.
🚩 Red Flags
- Planned leadership transition period: There is a significant gap between the announcement and the effective date (Sept 30), though an interim arrangement may be implied.
- Officer turnover in key financial roles can sometimes precede internal scrutiny, although the filing explicitly denies disagreement.
📋 Key Facts
- Chen Franco-Yehuda resigned as CFO, Treasurer, and Secretary effective September 30, 2024.
- Resignation is for personal reasons and not due to any disagreement with company operations or policies.
- Liat Zalts appointed as new CFO and Treasurer effective September 30, 2024.
- Zalts previously served as Director of Finance at Pluri since December 2022.
- Zalts has a background in audit at Ernst & Young (EY) Israel.
Pluri Inc. held its 2024 Annual Meeting of Stockholders on June 25, 2024. The filing reports the final results of stockholder voting regarding the election of directors and the ratification of the company's independent auditor.
📋 Key Facts
- The 2024 Annual Meeting of Stockholders was held on June 25, 2024.
- Five directors were elected: Zami Aberman, Doron Birger, Rami Levi, Maital Shemesh-Rasmussen, and Yaky Yanay.
- Kesselman & Kesselman (a member firm of PwC International Limited) was ratified as the independent registered public accounting firm for the fiscal year ending June 30, 2024.
- The voting results are reported as final.
Pluri Inc.'s majority-owned subsidiary, Ever After Foods Ltd., entered into a $10 million share purchase agreement to fund its B2B technology platform. As part of the deal, Pluri will invest $1.25 million and has amended its technology license agreement with the subsidiary to include fish and seafood applications.
🚩 Red Flags
- Dilution risk: The $10M private placement involves the issuance of ordinary shares in a subsidiary, which may impact the valuation/structure of the parent company's interest.
- Royalty waiver: Pluri is waiving certain license royalties to facilitate the deal, which could impact long-term cash flow from the subsidiary.
📋 Key Facts
- Ever After Foods Ltd. (majority-owned subsidiary) raised $10,000,000 in a private placement offering.
- Pluri Inc. is committing $1,250,000 to the funding round.
- Post-closing, Pluri will maintain approximately 69% ownership of Ever After Foods Ltd.
- The Amended and Restated Technology License Agreement expands the scope of technology use to include fish and seafood.
- Pluri has waived certain associated license royalties as part of the amended agreement.
Pluri Inc. received a deficiency letter from Nasdaq notifying the company that it is not in compliance with minimum stockholders' equity requirements for continued listing on the Nasdaq Capital Market.
🚩 Red Flags
- Delisting notice/Non-compliance with minimum stockholders' equity requirement
- Failure to meet alternative listing standards (market value and net income)
- Potential for delisting if a compliance plan is not accepted or implemented successfully
📋 Key Facts
- Received notice on May 28, 2024, regarding non-compliance with Nasdaq Listing Rule 5550(b)(1).
- The company failed to maintain the required $2,500,000 in stockholders' equity.
- Company also failed alternative listing standards: market value of listed securities ($35M) and net income from continuing operations ($500k).
- Pluri has 45 calendar days from the date of the letter to submit a plan to regain compliance.
- If a plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
Pluri Inc. has regained compliance with Nasdaq's minimum bid price requirement after a period of non-compliance. The company successfully maintained a closing bid price of $1.00 or greater for 10 consecutive business days.
🚩 Red Flags
- Historical delisting risk (though currently resolved)
📋 Key Facts
- The Company was previously notified on April 19, 2023, regarding non-compliance with Nasdaq Listing Rule 5550(a)(2) (minimum bid price).
- Nasdaq Staff determined the Company regained compliance as of April 15, 2024.
- Compliance was met by maintaining a closing bid price of $1.00 or greater for 10 consecutive business days between April 1, 2024, and April 12, 2024.
Pluri Inc. has announced a 1-for-8 reverse stock split effective April 1, 2024. This action reduces the number of outstanding common shares from approximately 41.8 million to approximately 5.2 million.
🚩 Red Flags
- Reverse stock split (often used to combat delisting or improve share price perception)
- Significant reduction in capital structure and authorized shares
📋 Key Facts
- Reverse split ratio: 1-for-8
- Effective Date: April 1, 2024, at 12:01 a.m. EST
- Authorized shares reduced from 300,000,000 to 37,500,000
- Outstanding shares reduced from ~41,816,959 to ~5,227,120
- New CUSIP Number: 72942G203
- No fractional shares will be issued; instead, one additional whole share will be issued to prevent fractions.
- The split was approved by the Board of Directors under Nevada law without shareholder approval.
Pluri Inc. entered into a sales agreement with A.G.P./Alliance Global Partners to facilitate the at-the-market (ATM) offering of common shares up to an aggregate amount of $10 million.
🚩 Red Flags
- Potential for significant shareholder dilution due to the $10 million ATM equity offering.
- Micro-cap companies often use ATM offerings to fund immediate working capital needs, which can signal liquidity constraints.
📋 Key Facts
- Entered into a Sales Agreement with A.G.P./Alliance Global Partners on February 13, 2024.
- The agreement allows for the issuance and sale of common shares up to an aggregate offering price of $10 million.
- Sales will be conducted via a shelf registration statement (Form S-3) effective as of September 21, 2023.
- A.G.P. will receive a cash commission of up to 3.0% of the gross proceeds.
- The offering can be executed through private transactions, block trades, or 'at the market' sales on Nasdaq.
Pluri Inc. announced the launch of a new business vertical, PluriAgtech, which focuses on cell-based coffee production to meet global demand for sustainable coffee. The new division will be led by Michal Ogolnik.
📋 Key Facts
- Launched 'PluriAgtech' as a new business vertical on January 23, 2024.
- The new vertical focuses on cell-based coffee production technology.
- Michal Ogolnik has been appointed to lead the PluriAgtech division.
- The move aims to address global demand for sustainable, mass-scale high-quality coffee.
Pluri Inc. announced the launch of a new business division, PluriCDMO™, which will provide cell therapy manufacturing services ranging from preclinical development to commercialization.
📋 Key Facts
- Launched new business division: PluriCDMO™ on January 8, 2024.
- Division focuses on Contract Development and Manufacturing Organization (CDMO) services for cell therapies.
- Services include early preclinical development through late-stage clinical trials and commercialization.
- The division will be led by Andy Lewin, described as an experienced CDMO executive.